Leptin-Melanocortin pathway variants and gastric emptying in patients with obesity
- PMID: 38361111
- PMCID: PMC11042991
- DOI: 10.1111/nmo.14764
Leptin-Melanocortin pathway variants and gastric emptying in patients with obesity
Abstract
Background: Accelerated gastric emptying (GE) is a trait seen in obesity. Mutations in the hypothalamic leptin-melanocortin 4 receptor (Leptin-MC4R) pathway have been associated with obesity. We sought to investigate the association of leptin-MC4R pathway variants and GE in patients with obesity.
Methods: This is a cross-sectional study of patients with a history of severe obesity that were genotyped and completed a GE test by scintigraphy. We evaluated the percentage of GE (GE %) at 2 and 4 h between both groups using ANCOVA with weight and sex as covariates. We subdivide patients into carriers based on the location of the identified variants (i.e., upstream or downstream of the Leptin-MC4R pathway) and compared them with noncarriers using ANOVA. Results are presented as mean and standard deviation (± SD).
Key results: A total of 95 patients; nine carriers (67% females; 39.78 ± 12.33 years; BMI: 49.14 ± 12.96 kg/m2) and 86 noncarriers (87% female; 49.98 ± 13.74 years; BMI: 40.75 ± 6.29 kg/m2) were included. At 2 and 4 h, carriers had a delayed GE when compared noncarriers (p = 0.03 and p = 0.005, respectively). In carriers, when compared upstream carriers vs. downstream carriers vs. noncarriers by location there was a significant difference in GE among groups at 2 h and at 4 h (p = 0.02 and p = 0.01, respectively).
Conclusions & inferences: Carriers of heterozygous variants in the Leptin-MC4R pathway had a delayed GE compared to noncarriers. These findings point the important relationship between the Leptin-MC4R pathway and gastric motility.
Keywords: accelerated gastric emptying; leptin‐MC4R pathway; obesity.
© 2024 John Wiley & Sons Ltd.
Similar articles
-
Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.J Clin Endocrinol Metab. 2018 Jul 1;103(7):2601-2612. doi: 10.1210/jc.2018-00258. J Clin Endocrinol Metab. 2018. PMID: 29726959 Free PMC article.
-
Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity.J Gastrointest Surg. 2004 Dec;8(8):971-81; discussion 981-2. doi: 10.1016/j.gassur.2004.09.032. J Gastrointest Surg. 2004. PMID: 15585384
-
Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case-Control Study.Obes Surg. 2022 Aug;32(8):2632-2640. doi: 10.1007/s11695-022-06122-9. Epub 2022 Jun 3. Obes Surg. 2022. PMID: 35654930 Free PMC article.
-
Treatment options for children with monogenic forms of obesity.World Rev Nutr Diet. 2013;106:105-12. doi: 10.1159/000342556. Epub 2013 Feb 11. World Rev Nutr Diet. 2013. PMID: 23428688 Review.
-
Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review.Int J Obes (Lond). 2013 Aug;37(8):1027-35. doi: 10.1038/ijo.2012.169. Epub 2012 Nov 13. Int J Obes (Lond). 2013. PMID: 23147118 Review.
References
-
- Larsen LH, Echwald SM, Sørensen TI, Andersen T, Wulff BS, Pedersen O. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. The Journal of Clinical Endocrinology & Metabolism. 2005;90(1):219–224. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical